Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. (ELOX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ELOX · as of Jun 13, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Eloxx Pharmaceuticals, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 13, 2026
ELOX insider buying and selling by quarter
ELOX insider selling · ELOX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 13, 2026
Active insiders
Most active in past 12 months · ELOX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ELOX executive sell shares · ELOX board member insider trading · ELOX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 27, 2026 | Coastlands Capital LP 10 percent owner | Other | 1,250,000 | — | Form 4 |
| Jan 24, 2026 | Rubin Steven D Director | Option | 1,875 | — | Form 4 |
| Feb 28, 2026 | Aggarwal Sumit President and CEO · Director | Option | 260,946 | $39K | Form 4 |
| Jan 24, 2026 | Aggarwal Sumit President and CEO · Director | Option | 15,000 | — | Form 4 |
| Sep 19, 2025 | Aggarwal Sumit President and CEO · Director | Award | 1,000,000 | — | Form 4 |
| Aug 14, 2025 | Aggarwal Sumit President and CEO · Director | Option | 196,880 | $20 | Form 4 |
| Jan 24, 2026 | Walts Alan Edmund Director | Option | 1,875 | — | Form 4 |
| Jan 24, 2025 | Aggarwal Sumit Director | Option | 30,000 | — | Form 4 |
| Jan 24, 2025 | Rubin Steven D Director | Option | 3,750 | — | Form 4 |
| Jan 24, 2025 | Androski Lindsay Director | Option | 3,750 | — | Form 4 |
| Jan 24, 2025 | Walts Alan Edmund Director | Option | 3,750 | — | Form 4 |
| Oct 16, 2024 | Walts Alan Edmund Director | Award | 12,000 | — | Form 4 |
| Oct 16, 2024 | Androski Lindsay Director | Award | 12,000 | — | Form 4 |
| Oct 16, 2024 | Rubin Steven D Director | Award | 12,000 | — | Form 4 |
| Oct 16, 2024 | Aggarwal Sumit PRESIDENT AND CEO · Director | Award | 165,000 | — | Form 4 |
| Dec 1, 2021 | Walts Alan Edmund Director | Option | 37,695 | — | Form 4 |
| Dec 1, 2021 | Aggarwal Sumit PRESIDENT AND CEO · Director | Option | 279,158 | — | Form 4 |
| Dec 1, 2021 | Aggarwal Sumit PRESIDENT AND CEO · Director | Other | 81,933 | $59K | Form 4 |
| Dec 1, 2021 | MODUR VIJAY HEAD OF R&D | Option | 219,326 | — | Form 4 |
| Dec 1, 2021 | MODUR VIJAY HEAD OF R&D | Other | 64,373 | $46K | Form 4 |
| Nov 29, 2021 | Geffken Daniel E. INTERIM CFO | Purchase | 50,000 | $36K | Form 4 |
| Jul 30, 2021 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Option | 1,563 | — | Form 4 |
| Jul 30, 2021 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Other | 459 | $606 | Form 4 |
| May 25, 2021 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Option | 6,250 | — | Form 4 |
| May 25, 2021 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Other | 1,835 | $3K | Form 4 |
Coastlands Capital LP
10 percent owner
Date
May 27
Shares
1,250,000
Price
—
Value
—
Aggarwal Sumit
President and CEO · Director
Date
Feb 28
Shares
260,946
Price
$0.15
Value
$39K
Aggarwal Sumit
President and CEO · Director
Date
Jan 24
Shares
15,000
Price
—
Value
—
Aggarwal Sumit
President and CEO · Director
Date
Sep 19
Shares
1,000,000
Price
—
Value
—
Aggarwal Sumit
President and CEO · Director
Date
Aug 14
Shares
196,880
Price
$0.00
Value
$20
Aggarwal Sumit
PRESIDENT AND CEO · Director
Date
Oct 16
Shares
165,000
Price
—
Value
—
Aggarwal Sumit
PRESIDENT AND CEO · Director
Date
Dec 1
Shares
279,158
Price
—
Value
—
Aggarwal Sumit
PRESIDENT AND CEO · Director
Date
Dec 1
Shares
81,933
Price
$0.72
Value
$59K
Belloff Neil S.
COO, GENERAL COUNSEL &CORP SEC
Date
Jul 30
Shares
1,563
Price
—
Value
—
Belloff Neil S.
COO, GENERAL COUNSEL &CORP SEC
Date
Jul 30
Shares
459
Price
$1.32
Value
$606
Belloff Neil S.
COO, GENERAL COUNSEL &CORP SEC
Date
May 25
Shares
6,250
Price
—
Value
—
Belloff Neil S.
COO, GENERAL COUNSEL &CORP SEC
Date
May 25
Shares
1,835
Price
$1.39
Value
$3K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ELOX insider trading
ELOX insider trades
Eloxx Pharmaceuticals, Inc. (ELOX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Aggarwal Sumit (President and CEO · Director), Coastlands Capital LP (10 percent owner), Rubin Steven D (Director). Over the past 12 months, 4 insiders have filed transactions with the SEC. ELOX insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Eloxx Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ELOX insider trading · 5 questionsThe insiders of Eloxx Pharmaceuticals, Inc. (ELOX) include executives and directors such as Aggarwal Sumit (President and CEO · Director), Coastlands Capital LP (10 percent owner), Rubin Steven D (Director), among others. Over the past 12 months, 4 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 13, 2026